BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25676387)

  • 41. The development of an online database for interventions tested in transgenic mouse models of Alzheimer's disease.
    Egan KJ; Vesterinen HM; McCann SK; Sena ES; MacLeod MR
    Evid Based Preclin Med; 2015 Aug; 2(1):e00010. PubMed ID: 27570629
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Repurposing historical control clinical trial data to provide safety context.
    Bhuyan P; Desai J; Louis MS; Carlsson M; Bowen E; Danielson M; Cantor MN
    Drug Discov Today; 2016 Feb; 21(2):212-6. PubMed ID: 26523771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Review of selected databases of longitudinal aging studies.
    Erten-Lyons D; Sherbakov LO; Piccinin AM; Hofer SM; Dodge HH; Quinn JF; Woltjer RL; Kramer PL; Kaye JA
    Alzheimers Dement; 2012 Nov; 8(6):584-9. PubMed ID: 23102128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mobile and pervasive computing technologies and the future of Alzheimer's clinical trials.
    Doraiswamy PM; Narayan VA; Manji HK
    NPJ Digit Med; 2018; 1():1. PubMed ID: 31304287
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of hypothesis testing in clinical trials.
    Schneider B
    Methods Inf Med; 1981 Apr; 20(2):65-6. PubMed ID: 7242375
    [No Abstract]   [Full Text] [Related]  

  • 46. Open access data sharing from clinical trials: is it really feasible?
    Flather M
    Eur Heart J Qual Care Clin Outcomes; 2015 Nov; 1(2):49-50. PubMed ID: 29474599
    [No Abstract]   [Full Text] [Related]  

  • 47. Building a roadmap for developing combination therapies for Alzheimer's disease.
    Perry D; Sperling R; Katz R; Berry D; Dilts D; Hanna D; Salloway S; Trojanowski JQ; Bountra C; Krams M; Luthman J; Potkin S; Gribkoff V; Temple R; Wang Y; Carrillo MC; Stephenson D; Snyder H; Liu E; Ware T; McKew J; Fields FO; Bain LJ; Bens C
    Expert Rev Neurother; 2015 Mar; 15(3):327-33. PubMed ID: 25708309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differences in Alzheimer disease clinical trial outcomes based on age of the participants.
    Schneider LS; Kennedy RE; Wang G; Cutter GR
    Neurology; 2015 Mar; 84(11):1121-7. PubMed ID: 25681452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comment: Age effects on clinical trial results in Alzheimer dementia.
    Brashear HR
    Neurology; 2015 Mar; 84(11):1126. PubMed ID: 25681449
    [No Abstract]   [Full Text] [Related]  

  • 51. Emerging drug targets for Aβ and tau in Alzheimer's disease: a systematic review.
    West S; Bhugra P
    Br J Clin Pharmacol; 2015 Aug; 80(2):221-34. PubMed ID: 25753046
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease.
    Karami A; Eyjolfsdottir H; Vijayaraghavan S; Lind G; Almqvist P; Kadir A; Linderoth B; Andreasen N; Blennow K; Wall A; Westman E; Ferreira D; Kristoffersen Wiberg M; Wahlund LO; Seiger Å; Nordberg A; Wahlberg L; Darreh-Shori T; Eriksdotter M
    Alzheimers Dement; 2015 Nov; 11(11):1316-28. PubMed ID: 25676388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sponsors meet scientists to speed pediatric medicines development.
    Davis JM; Smoyer WE; Connor EM; Huskins WC; Pastern C; Purucker M; Schrader EC; Jackson CR; Kaskel FJ; Hirschfeld S
    Sci Transl Med; 2015 Mar; 7(279):279fs11. PubMed ID: 25787760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is lithium a neuroprotective agent?
    Vo TM; Perry P; Ellerby M; Bohnert K
    Ann Clin Psychiatry; 2015 Feb; 27(1):49-54. PubMed ID: 25696782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. APOE-modulated Aβ-induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective.
    Tai LM; Ghura S; Koster KP; Liakaite V; Maienschein-Cline M; Kanabar P; Collins N; Ben-Aissa M; Lei AZ; Bahroos N; Green SJ; Hendrickson B; Van Eldik LJ; LaDu MJ
    J Neurochem; 2015 May; 133(4):465-88. PubMed ID: 25689586
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cognitive and Functional Decline in Patients With Mild Alzheimer Dementia With or Without Comorbid Diabetes.
    Ascher-Svanum H; Chen YF; Hake A; Kahle-Wrobleski K; Schuster D; Kendall D; Heine RJ
    Clin Ther; 2015 Jun; 37(6):1195-205. PubMed ID: 25676448
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tracking early decline in cognitive function in older individuals at risk for Alzheimer disease dementia: the Alzheimer's Disease Cooperative Study Cognitive Function Instrument.
    Amariglio RE; Donohue MC; Marshall GA; Rentz DM; Salmon DP; Ferris SH; Karantzoulis S; Aisen PS; Sperling RA;
    JAMA Neurol; 2015 Apr; 72(4):446-54. PubMed ID: 25706191
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Should early cranial MRI of preterm infants become routine?
    De Vries LS; Benders MJ; Groenendaal F
    Arch Dis Child Fetal Neonatal Ed; 2015 Jul; 100(4):F284-5. PubMed ID: 25825480
    [No Abstract]   [Full Text] [Related]  

  • 59. Neuroinflammation in Alzheimer's disease.
    Heneka MT; Carson MJ; El Khoury J; Landreth GE; Brosseron F; Feinstein DL; Jacobs AH; Wyss-Coray T; Vitorica J; Ransohoff RM; Herrup K; Frautschy SA; Finsen B; Brown GC; Verkhratsky A; Yamanaka K; Koistinaho J; Latz E; Halle A; Petzold GC; Town T; Morgan D; Shinohara ML; Perry VH; Holmes C; Bazan NG; Brooks DJ; Hunot S; Joseph B; Deigendesch N; Garaschuk O; Boddeke E; Dinarello CA; Breitner JC; Cole GM; Golenbock DT; Kummer MP
    Lancet Neurol; 2015 Apr; 14(4):388-405. PubMed ID: 25792098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel approach to delayed-start analyses for demonstrating disease-modifying effects in Alzheimer's disease.
    Liu-Seifert H; Andersen SW; Lipkovich I; Holdridge KC; Siemers E
    PLoS One; 2015; 10(3):e0119632. PubMed ID: 25781335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.